Product information
From Health Canada
Current status:
Cancelled Post Market
Current status date:
1998-08-11
Original market date: See footnote 1
1997-06-18
Product name:
LAXCODYL
DIN:
02201763 Electronic product monograph is not available
Company:
TANTA PHARMACEUTICALS INC
1009 Burns Street East
Whitby
Ontario
Canada
L1N 6A6
Class:
Human
Dosage form(s):
Suppository
Route(s) of administration:
Rectal
Number of active ingredient(s):
1
Schedule(s):
OTC
American Hospital Formulary Service (AHFS): See footnote 3
56:12.00
Anatomical Therapeutic Chemical (ATC): See footnote 4
A06AB02 BISACODYL
Active ingredient group (AIG) number:See footnote5
0101506002
Active ingredient(s) | Strength |
---|---|
BISACODYL | 10 MG / SUP |